# Impact of IL-28B rs12979860 and rs4803217 Gene Polymorphisms Associated With miRNAs Deregulation on HCV-related Hepatocellular Carcinoma

> **NCT02507882** · NA · UNKNOWN · sponsor: **Dr.Waleed Samir** · enrollment: 405 (estimated)

## Conditions studied

- HCV Infection ( Genotype 4)

## Interventions

- **BIOLOGICAL:** IL28B Polymorphism
- **BIOLOGICAL:** miRNA quantification

## Key facts

- **NCT ID:** NCT02507882
- **Lead sponsor:** Dr.Waleed Samir
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-01
- **Primary completion:** 2017-12
- **Final completion:** —
- **Target enrollment:** 405 (ESTIMATED)
- **Last updated:** 2015-07-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02507882

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02507882, "Impact of IL-28B rs12979860 and rs4803217 Gene Polymorphisms Associated With miRNAs Deregulation on HCV-related Hepatocellular Carcinoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02507882. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*